Home Life Sciences Extracellular fibrin promotes non-small cell lung cancer progression through integrin β1/PTEN/AKT signaling
Article Open Access

Extracellular fibrin promotes non-small cell lung cancer progression through integrin β1/PTEN/AKT signaling

  • Guilong Li , Jiaying Cai , Jianjun Xie and Yizhi Dai EMAIL logo
Published/Copyright: September 19, 2023

Abstract

The extracellular matrix (ECM) has been strongly correlated with cancer progression in various tumor types. However, the specific mechanisms underlying ECM-associated tumor behaviors remain unclear. In this study, we found an enriched distribution of fibrin in tumor tissues obtained from high-grade non-small cell lung cancer (NSCLC) patients. For further investigation, we established an in vitro 3D culture system using fibrin gel and found that NSCLC cells grown in this system exhibited increased stemness and tumorigenesis. Mechanistically, we demonstrated that fibrin facilitated the activation of the phosphatase and tensin homolog (PTEN)/protein kinase B (AKT) signaling pathway through integrin β1. Furthermore, we found that blocking integrin β1 signals enhanced the tumor suppressive effects of chemotherapy, providing a novel approach for clinical therapy for NSCLC.

Graphical abstract

1 Introduction

Lung carcinoma is the most common malignant tumor and the leading cause of cancer-associated mortality worldwide [1]. Despite advancements in pre-clinical diagnosis and therapy for localized non-small cell lung cancer (NSCLC), patients still face challenges due to cancer development and distant metastasis driven by NSCLC stem cells [2]. The mechanisms underlying NSCLC progression remain controversial, emphasizing the need to explore these mechanisms and develop innovative approaches to eliminate tumor cells.

Tumor progression involves various biological processes, including oncogene mutations [3], crosstalk between immune cells and cancer cells [4], and extracellular matrix (ECM)-mediated remodeling of tumor stemness [5]. Fibrin, a non-globular fibrous protein associated with blood clotting, is one of the components of the ECM [6,7]. In recent years, increasing evidence has demonstrated the significant involvement of plasma-derived fibrinogen and its activated form, fibrin, in tumor formation, invasion, and metastasis [8,9]. Fibrinogen, a pivotal protein in blood coagulation [10], becomes activated and polymerizes to form fibrin clots following injury. Within the tumor microenvironment, the abundance of vascular tissue frequently leads to the aggregation of fibrinogen or fibrin [11]. Consequently, the presence of fibrin enhances the invasive capacity of tumor cells and offers an ideal avenue for regulating the interplay between tumor cells and their surrounding milieu. Moreover, fibrin is closely associated with tumor angiogenesis, immune evasion, and metastatic processes [12]. Mechanistically, fibrin facilitates the migration and infiltration of tumor cells through various mechanisms, including thrombin activation [13], promotion of angiogenesis [12], and regulation of tumor cell–matrix interactions [14]. Additionally, fibrin regulates the release of cytokines and growth factors within the tumor microenvironment. Fibrin deposition can also create a provisional matrix enriched in growth factors that promote tumor stemness and the capability of cell proliferation [15]. Current studies have provided evidence suggesting that fibrin may participate in the regulation of tumor progression in various tumor types, including lung cancer [16], breast cancer [17], and bladder cancer [18]. Liu et al. reported that fibrin-based 3D gels could promote the proliferation of tumor-repopulating cells in various cancer cell lines, such as melanoma and lung cancer cells [19]. Although enriched fibrin distribution has been observed in various tumor types [2023], the molecular mechanisms by which fibrin contributes to the progression of NSCLC remain unknown.

Our study found enriched fibrin distribution in tumor tissues obtained from high-grade NSCLC patients. To investigate the effects of fibrin on NSCLC cells, we employed an in vitro 3D culture system utilizing fibrin gels. Within these 3D fibrin culture gels, NSCLC cells exhibited enhanced stemness and tumorigenic capabilities. Furthermore, the response of NSCLC cells to fibrin was dependent on the presence of the cell surface integrin β1 receptor, leading to the activation of downstream PTEN/AKT signals and stimulation of tumor growth. Based on these findings, we aimed to investigate the potential of suppressing integrin β1 signaling to enhance the tumor-suppressive effects of chemotherapeutic agents, thereby providing a novel approach for NSCLC therapy.

2 Materials and methods

2.1 NSCLC cell culture and reagent system

The NSCLC A549 and NCI-H1299 human cells were purchased from the American General Cultural Protection Center and cultured in RPMI-1640 complete media supplemented with 10% fetal bovine serum (Gibco, MA, USA). Fibrin gels were obtained from Sea Run Holdings, Inc. (NJ, USA). Neutralizing antibodies against integrin β1 and integrin β3 were obtained from Selleck Chemicals (NJ, USA). The AKT inhibitor capivasertib was obtained from MedChemExpress (NJ, USA). Cisplatin (Cis) and paclitaxel (PTX) were purchased from Sangon Biotech (Shanghai, China).

2.2 Preservation of patient tumor tissue

A total of 22 NSCLC tissues, fixed using formalin and embedded in paraffin, were obtained from the Zhangzhou Affiliated Hospital of Fujian Medical University. The tissue samples were divided into the high-degree (H-D, stage III, n = 11) and low-degree (L-D, stages I–II, n = 11) groups. All patients were diagnosed with NSCLC and provided written consent to participate in the study. Sample collection and processing adhered to the guidelines outlined in the Helsinki Declaration. This study received approval from the Zhangzhou Affiliated Hospital of Fujian Medical University.

  1. Informed consent: Informed consent has been obtained from all individuals included in this study.

  2. Ethical approval: The research related to human use has been complied with all the relevant national regulations, institutional policies and in accordance with the tenets of the Helsinki Declaration, and has been approved by Ethics Committee of Zhangzhou Affiliated Hospital of Fujian Medical University.

2.3 3D collagen/fibrin culture gel

For the 3D collagen culture system, collagen I (Corning, CA, USA) was diluted to a concentration of 2.5 mg/mL using a cell suspension. To this mixture, 25 μL of PBS and 20 μL of 1 N NaOH were added, resulting in a total volume of 300 μL. The 300 μL collagen mixture was then seeded into a 24-well plate and cultured at 37°C for 90 min. The collagen mixture solidified, after which 1 mL of culture medium was added to the system. After 5 days, the colonies were counted and colony formation was analyzed.

For the 3D fibrin gel culture, fibrin gels were diluted to a concentration of 2 mg/mL using the culture medium. Then, the fibrin gels were further diluted to a concentration of 1 mg/mL with a cell suspension (1,000 cells in a 300 μL mixture). The 300 μL mixture was seeded into a 24-well plate, mixed with 2.5 μL thrombin (0.1 U/mL, Corning, CA, USA), and cultured at 37°C for 90 min. The fibrin mixture solidified, and 1 mL of culture medium was added to the system. After 5 days, the colonies were counted and colony formation was analyzed.

To collect tumor cells from the 3D fibrin or collagen gels, the culture medium was removed from a 24-well plate. Then, 1 mL of Dispase working solution (Corning, CA, USA) was added to the 24-well plate containing the gels and cells. The samples were cultured at 37°C for 10 min, causing the gels to liquefy. Subsequently, samples were added to 5 mL of PBS and centrifuged at 500 g for 5 min. The supernatant was removed, and tumor cells were collected for further analysis.

2.4 Colony formation analysis

To monitor the 3D colony formation, A549 or NCI-H1299 cells (2,000 cells) were cultured in a 3D fibrin (1 mg/mL) or 3D collagen (2.5 mg/mL) gel and incubated at 37°C for 1 h. Then, 1 mL of culture medium was added to the 24-well plate. After 5 days, the colonies were counted and colony formation was analyzed.

To monitor the 2D flask colony formation, A549 or NCI-H1299 cells (1,000 cells) were cultured in a six-well plate in a complete culture medium. After 10 days, the colonies were counted and colony formation was analyzed.

2.5 Cell death and apoptosis analysis

Cell death and apoptosis analysis was conducted using the FITC-Annexin V and PE-PI staining kit (BD, NJ, USA). A549 or NCI-H1299 cells cultured in either 3D or flask formats were collected and treated with the FITC-Annexin V and PE-PI staining solution for 30 min. Then, cell apoptosis was analyzed using a C6 flow cytometer (BD, NJ, USA).

2.6 Flow cytometry

The cell pellet was resuspended and washed with PBS supplemented with 2% BSA. Then, the samples were stained with the anti-CD133 primary antibodies (Thermo Fisher, MA, USA) for 20 min at 4°C. The isotype was set as the negative control. Subsequently, the samples were analyzed using a C6 flow cytometer (BD, NJ, USA).

2.7 Western blotting

The protein lysates obtained from A549 and NCI-H1299 cells were subjected to SDS–PAGE to separate the proteins, which were then transferred onto polyvinylidene fluoride membranes (Thermo Fisher, MA, USA). The membranes were subsequently incubated with primary antibodies, including anti-integrin β1 (1:1,000; Abcam, Cambridge, UK), anti-PTEN (1:1,000; Abcam, Cambridge, UK), anti-p-AKT (1:500; Abcam, Cambridge, UK), anti-AKT (1:500; Abcam, Cambridge, UK), and anti-β-actin (1:1,000; Abcam, Cambridge, UK). This was followed by treatment with HRP-conjugated secondary antibodies (1:1,000; Abcam, Cambridge, UK).

2.8 qPCR analysis

mRNA levels were quantified by real-time PCR using SYBR Green dye (Thermo Fisher, MA, USA). GAPDH was used as the reference gene for normalization. The primers used are listed as follows: human GAPDH forward primer 5′-GGAGCGAGATCCCTCCAAAAT-3′, reverse primer 5′-GGCTGTTGTCATACTTCTCATGG-3′; human SOX2 forward primer 5′-GCCGAGTGGAAACTTTTGTCG-3′, reverse primer 5′-GGCAGCGTGTACTTATCCTTCT-3′; human c-Myc forward primer 5′-GGCTCCTGGCAAAAGGTCA-3′, reverse primer 5′-CTGCGTAGTTGTGCTGATGT-3′; human Oct3/4 forward primer 5′-CTGGGTTGATCCTCGGACCT-3′, reverse primer 5′-CCATCGGAGTTGCTCTCCA-3′; human Klf4 forward primer 5′-CCCACATGAAGCGACTTCCC-3′, reverse primer 5′-CAGGTCCAGGAGATCGTTGAA-3′. Each experiment was repeated independently in triplicate.

2.9 Immunohistochemical staining

The NSCLC tissues were fixed in 4% paraformaldehyde for 72 h and then sectioned. The samples were deparaffinized and rehydrated using alcohol and water. For antigen recovery, the samples were treated with sodium citrate buffer at 100℃ for 5 min. For blocking, 5% BSA was used. Subsequently, the samples were incubated overnight at 4℃ with primary antibodies: anti-fibrin α subunit (1:100; Abcam, Cambridge, UK), anti-p-AKT (1:100; Abcam, Cambridge, UK), anti-integrin β1 (1:100; Abcam, Cambridge, UK), and anti-PTEN (1:200; Abcam, Cambridge, UK). Finally, the detection was carried out using the ABC HPR Kit (Thermo Fisher, MA, USA).

2.10 Animal experiments

Female NOD-SCID mice, 8 weeks old, were obtained from Huafukang Company (Beijing, China) and raised in a specific pathogen-free room. All animal procedures were approved by the Hospital Animal Care and Use Committee at Zhangzhou Affiliated Hospital of Fujian Medical University. For tumorigenic potential analysis, a total of 1 × 105 A549 or NCI-H1299 cells were subcutaneously implanted into mice. Subsequently, tumors were counted after 30 days (n = 10 per group).

For the subcutaneous tumor model, mice were injected with 2 × 106 A549 cells subcutaneously. After 2 weeks, the mice were randomly divided into four groups (n = 6 per group). The groups were treated with PBS, integrin β1 neutralizing antibodies (10 μg per mouse, intratumoral injection), Cis (5 mg/kg, intravenous injection), or PTX (20 mg/kg, intravenous injection) every 3 days. Tumor volume was calculated using the formula: Tumor volume = (length × width2)/2.

  1. Ethical approval: The research related to animal use has been complied with all the relevant national regulations and institutional policies for the care and use of animals, and has been approved by the Ethics Committee of Zhangzhou Affiliated Hospital of Fujian Medical University.

2.11 Statistical analysis

Each experiment was performed in triplicate. The data were expressed as the mean ± standard deviation. Statistical analysis was carried out using GraphPad Prism 6.0 (LJ, USA) and SPSS 22.0 software (Chicago, USA). Differences between groups were determined using the analysis of variance or Student’s t-test. A P-value < 0.05 was considered statistically significant.

3 Results

3.1 3D fibrin culture promoted NSCLC stemness

Increasing evidence indicates that a 3D culture system utilizing fibrin enhances the stemness of tumor cells in various types of cancer, including melanoma, breast cancer, and hepatoma cells [24,25]. Therefore, we implemented a 3D fibrin gel culture system for NSCLC cell lines (A549 and NCI-H1299) to determine the effects of fibrin on NSCLC progression. Compared to the traditional 3D collagen gel culture system, NSCLC cells cultured in the fibrin gel system exhibited an increased capability of colony formation (Figure 1a) and reduced apoptosis (Figure 1b). Moreover, NSCLC cells in fibrin gels exhibited proliferative characteristics (Figure 1c), whereas cells in collagen exhibited high apoptotic rates (>80%) on day 5. These results indicate that 3D fibrin gel culture facilitates NSCLC cell colony formation. We also examined the expression of CD133, a marker of NSCLC stem cells, in 3D fibrin gel-cultured NSCLC cells. Both A549 and HCI-H1299 cells cultured in 3D fibrin gel showed increased CD133 expression compared to the flask group (Figure 1d). We also evaluated the colony formation capability and tumorigenic potential of these 3D fibrin-cultured NSCLC cells. Consistently, 3D fibrin culture significantly enhanced the colony formation capability of NSCLC cells (Figure 1e). In vivo studies demonstrated an enhanced tumorigenic capability in 3D fibrin-cultured A549 and NCI-H1299 cells (Figure 1f), indicating that 3D fibrin gel promotes the stemness of NSCLC cells. Finally, we investigated fibrin distribution in tumor samples obtained from clinical patients. Immunohistochemical staining of the fibrin alpha chain (a component of fibrin) showed elevated expression of fibrin in high-degree (H-D, stage III) tumor tissues compared to the low-degree (L-D, stage I–II) group (Figure 1g). These results suggest that fibrin promotes the tumor stemness of NSCLC cells.

Figure 1 
                  3D fibrin promoted NSCLC stemness. (a) Colony formation rates of A549 and NCI-H1299 cells seeded in 3D fibrin and collagen gels. The colonies were pictured on day 3 and the scale bar is 50 μm. (b) Cells apoptosis of A549 and NCI-H1299 cells seeded in 3D fibrin and collagen gels on day 5. (c) Colonies of A549 and NCI-H1299 cells seeded in 3D fibrin were pictured on days 2 and 5. The scale bar is 50 μm. (d) CD133 positive cells proportion in A549 and NCI-H1299 cells seeded in 3D fibrin on day 5. (e) Colony formation of A549 and NCI-H1299 cells cultured in dish or 3D fibrin gels. (f) Tumorigenesis of A549 and NCI-H1299 cells cultured in dish or 3D fibrin gels. (g) Immunohistochemical staining of fibrin in tumor tissues from high degree (H-D) and low degree (L-D) NSCLC patients (n = 11 in each group). The protein level was quantified. The scale bar is 50 μm. * indicates P < 0.05. ** indicates P < 0.01. *** indicates P < 0.001.
Figure 1

3D fibrin promoted NSCLC stemness. (a) Colony formation rates of A549 and NCI-H1299 cells seeded in 3D fibrin and collagen gels. The colonies were pictured on day 3 and the scale bar is 50 μm. (b) Cells apoptosis of A549 and NCI-H1299 cells seeded in 3D fibrin and collagen gels on day 5. (c) Colonies of A549 and NCI-H1299 cells seeded in 3D fibrin were pictured on days 2 and 5. The scale bar is 50 μm. (d) CD133 positive cells proportion in A549 and NCI-H1299 cells seeded in 3D fibrin on day 5. (e) Colony formation of A549 and NCI-H1299 cells cultured in dish or 3D fibrin gels. (f) Tumorigenesis of A549 and NCI-H1299 cells cultured in dish or 3D fibrin gels. (g) Immunohistochemical staining of fibrin in tumor tissues from high degree (H-D) and low degree (L-D) NSCLC patients (n = 11 in each group). The protein level was quantified. The scale bar is 50 μm. * indicates P < 0.05. ** indicates P < 0.01. *** indicates P < 0.001.

3.2 Fibrin facilitates NSCLC stemness through integrin β1 signals

The ECM has been shown to play a crucial role in promoting tumor progression by activating integrin-associated signals [26]. Previous studies have identified integrin β3 as a mediator of cellular mechanical signals from the 3D ECM [27]. In this study, we added integrin β3 neutralizing antibodies to the 3D fibrin gel culture system and examined their impact on the colony formation capability of NSCLC cells. However, no significant suppressive effects on colony formation (Figure 2a) or size (Figure 2b) were observed. We then shifted our focus to integrin β1, which has been reported to regulate tumor stemness in colorectal and breast cancer. Interestingly, treatment with integrin β1 neutralizing antibodies significantly suppressed the colony formation (Figure 2c) and growth (Figure 2d) of A549 and NCI-H1299 in 3D fibrin gels. Furthermore, when we collected the integrin β1 neutralizing antibody-treated NSCLC cells in fibrin gels, we observed poor colony formation (Figure 2e) and tumorigenesis (Figure 2f), indicating the crucial role of integrin β1 in NSCLC cells. We also detected elevated expression of integrin β1 in NSCLC cells cultured in 3D fibrin gels (Figure 2g) and in tumor tissues from patients with high-degree NSCLC (Figure 2h). These findings suggest that fibrin promotes NSCLC progression through integrin β1 signals.

Figure 2 
                  Fibrin facilitated NSCLC stemness through integrin β1. (a) Colony formation rates of 3D fibrin cultured A549 and NCI-H1299 cells treated with PBS and integrin β3 neutralizing antibody (25 μg/mL). (b) Colonies in (a) were pictured on day 3 and the scale bar is 50 μm. (c) Colony formation rates of 3D fibrin cultured A549 and NCI-H1299 cells treated with PBS and integrin β1 neutralizing antibody (25 μg/mL). (d) Colonies in (c) were pictured on day 3 and the scale bar is 50 μm. (e) Colony formation of 3D fibrin gel cultured A549 and NCI-H1299 cells treated with PBS and integrin β1 neutralizing antibody (25 μg/mL). (f) Tumorigenesis of 3D fibrin gel cultured A549 and NCI-H1299 cells treated with PBS and integrin β1 neutralizing antibody (25 μg/mL). (g) Western blotting of integrin β1 in A549 and NCI-H1299 cells cultured in dish or 3D fibrin gels. (h) Immunohistochemical staining of integrin β1 in tumor tissues from high degree (H-D) and low degree (L-D) NSCLC patients (n = 11 in each group). The protein level was quantified. The scale bar is 50 μm. * indicates P < 0.05. ** indicates P < 0.01. n.s. indicates no statistical significance.
Figure 2

Fibrin facilitated NSCLC stemness through integrin β1. (a) Colony formation rates of 3D fibrin cultured A549 and NCI-H1299 cells treated with PBS and integrin β3 neutralizing antibody (25 μg/mL). (b) Colonies in (a) were pictured on day 3 and the scale bar is 50 μm. (c) Colony formation rates of 3D fibrin cultured A549 and NCI-H1299 cells treated with PBS and integrin β1 neutralizing antibody (25 μg/mL). (d) Colonies in (c) were pictured on day 3 and the scale bar is 50 μm. (e) Colony formation of 3D fibrin gel cultured A549 and NCI-H1299 cells treated with PBS and integrin β1 neutralizing antibody (25 μg/mL). (f) Tumorigenesis of 3D fibrin gel cultured A549 and NCI-H1299 cells treated with PBS and integrin β1 neutralizing antibody (25 μg/mL). (g) Western blotting of integrin β1 in A549 and NCI-H1299 cells cultured in dish or 3D fibrin gels. (h) Immunohistochemical staining of integrin β1 in tumor tissues from high degree (H-D) and low degree (L-D) NSCLC patients (n = 11 in each group). The protein level was quantified. The scale bar is 50 μm. * indicates P < 0.05. ** indicates P < 0.01. n.s. indicates no statistical significance.

3.3 3D fibrin promotes tumor progression through PTEN/AKT signals

PTEN, a commonly altered tumor suppressor [28], was found to be downregulated in NSCLC cells cultured in our 3D fibrin gels (Figure 3a). Importantly, the suppression of integrin β1 prevented the downregulation of PTEN caused by fibrin gels (Figure 3a), indicating that 3D fibrin gels may regulate NSCLC cells through PTEN-associated signals. We then examined the downstream molecule of PTEN, AKT, in NSCLC cells cultured in the 3D fibrin culture system. Consistently, A549 and NCI-H1299 cells in the 3D fibrin culture system exhibited elevated expression of phosphorylated AKT, which was attenuated by inhibition of integrin β1 (Figure 3b). In addition, treatment of flask-cultured NSCLC cells with the PTEN inhibitor bpV(HOpic) significantly upregulated the expression of phosphorylated AKT (Figure 3c), indicating that 3D fibrin gels stimulated the activation of the PTEN/AKT signaling pathway through integrin β1. To investigate the effect of PTEN/AKT signals on NSCLC, we treated 3D fibrin gel-cultured NSCLC cells with the AKT inhibitor capivasertib. Consequently, capivasertib treatment suppressed colony formation (Figure 3d) and growth (Figure 3e) of NSCLC cells in 3D fibrin gels. Suppression of AKT signaling also inhibited colony formation (Figure 3f) and tumorigenesis (Figure 3g) of NSCLC cells cultured in 3D fibrin gels. Immunohistochemical staining revealed decreased PTEN and increased phosphorylated AKT expression in tumor tissues from patients with high-degree NSCLC (Figure 3h and i), highlighting the crucial role of PTEN/AKT signaling in NSCLC. Furthermore, we examined the expression of pro-survival transcription factors downstream of AKT, including SOX2, c-Myc, c-Kit, Oct3/4, and Klf4. We found increased expression of SOX2 and c-Myc in NSCLC cells cultured in the 3D fibrin culture system, which was reversed by blocking AKT signaling (Figure 3j). These results suggest that 3D fibrin gels promote NSCLC cells through the integrin β1/PTEN/AKT signaling pathway.

Figure 3 
                  3D fibrin promoted tumor progression through PTEN/AKT signals. (a) Western blotting of PTEN in A549 and NCI-H1299 cells cultured in dish or 3D fibrin gels (treated with PBS or 25 μg/mL integrin β1 neutralizing antibody). (b) Western blotting of phosphorylated/total AKT in A549 and NCI-H1299 cells cultured in dish or 3D fibrin gels (treated with PBS or 25 μg/mL integrin β1 neutralizing antibody). (c) Western blotting of phosphorylated/total AKT in A549 and NCI-H1299 cells treated with PBS or BpV(HOpic) (10 μM). (d) 3D fibrin gel colony formation rate of A549 and NCI-H1299 cells treated with PBS or capivasertib (20 μM). (e) Colonies in (d) were pictured on day 3 and the scale bar is 50 μm. (f) Colony formation rates of 3D fibrin gel cultured A549 and NCI-H1299 cells treated with PBS or capivasertib (20 μM). (g) Tumorigenesis of 3D fibrin gel cultured A549 and NCI-H1299 cells treated with PBS or capivasertib (20 μM). (h) Immunohistochemical staining of PTEN in tumor tissues from high degree (H-D) and low degree (L-D) NSCLC patients (n = 11 in each group). The protein level was quantified. The scale bar is 50 μm. (i) Immunohistochemical staining of phosphorylated AKT in tumor tissues from high degree (H-D) and low degree (L-D) NSCLC patients (n = 11 in each group). The protein level was quantified. The scale bar is 50 μm. (j) Relative expression of SOX2, c-Myc, c-Kit, Oct3/4, and Klf4 in A549 and NCI-H1299 cells cultured in dish or 3D fibrin gels (treated with PBS or 20 μM capivasertib) using qPCR. * indicates P < 0.05. ** indicates P < 0.01.
Figure 3

3D fibrin promoted tumor progression through PTEN/AKT signals. (a) Western blotting of PTEN in A549 and NCI-H1299 cells cultured in dish or 3D fibrin gels (treated with PBS or 25 μg/mL integrin β1 neutralizing antibody). (b) Western blotting of phosphorylated/total AKT in A549 and NCI-H1299 cells cultured in dish or 3D fibrin gels (treated with PBS or 25 μg/mL integrin β1 neutralizing antibody). (c) Western blotting of phosphorylated/total AKT in A549 and NCI-H1299 cells treated with PBS or BpV(HOpic) (10 μM). (d) 3D fibrin gel colony formation rate of A549 and NCI-H1299 cells treated with PBS or capivasertib (20 μM). (e) Colonies in (d) were pictured on day 3 and the scale bar is 50 μm. (f) Colony formation rates of 3D fibrin gel cultured A549 and NCI-H1299 cells treated with PBS or capivasertib (20 μM). (g) Tumorigenesis of 3D fibrin gel cultured A549 and NCI-H1299 cells treated with PBS or capivasertib (20 μM). (h) Immunohistochemical staining of PTEN in tumor tissues from high degree (H-D) and low degree (L-D) NSCLC patients (n = 11 in each group). The protein level was quantified. The scale bar is 50 μm. (i) Immunohistochemical staining of phosphorylated AKT in tumor tissues from high degree (H-D) and low degree (L-D) NSCLC patients (n = 11 in each group). The protein level was quantified. The scale bar is 50 μm. (j) Relative expression of SOX2, c-Myc, c-Kit, Oct3/4, and Klf4 in A549 and NCI-H1299 cells cultured in dish or 3D fibrin gels (treated with PBS or 20 μM capivasertib) using qPCR. * indicates P < 0.05. ** indicates P < 0.01.

3.4 Inhibition of integrin signaling improves the anticancer effects of chemotherapeutic agents

Our in vitro results have demonstrated that 3D fibrin gels can activate PTEN/AKT signals through integrin β1, indicating that blocking integrin β1 may enhance the efficacy of NSCLC therapy. To investigate this further, we used A549 cells to establish a subcutaneous NSCLC mouse model. Tumor-bearing mice were treated with PBS, integrin β1 neutralizing antibodies, PTX, or a combination of PTX and integrin β1 neutralizing antibodies. The results showed that treatment with integrin β1 neutralizing antibodies, in combination with PTX, effectively inhibited tumor growth and significantly prolonged the overall survival of mice (Figure 4a and b). Similar results were observed with the combination of Cis and integrin β1 neutralizing antibody treatment (Figure 4c and d). To further investigate their clinical relevance in malignant NSCLC, 3D fibrin gel-cultured A549 cells were injected into mice to establish an NSCLC model. Fibrin (1 μg per mouse) was injected into the tumor sites on days 10 and 15 to promote NSCLC progression. Subsequently, the tumor-bearing mice were treated with a combination of integrin β1 neutralizing antibodies and PTX. Interestingly, single PTX treatments showed limited anticancer effects, potentially due to drug resistance induced by fibrin. However, the combination of PTX and integrin β1 neutralizing antibodies effectively inhibited tumor growth and significantly prolonged the survival time of the mice (Figure 4e and f). These results indicate that suppressing integrin β1 signals effectively enhances the tumor-suppressive effects of chemotherapeutic agents, offering a novel therapeutic strategy for NSCLC.

Figure 4 
                  Suppression of integrin signals strengthened anticancer effects of chemotherapy. (a) Tumor volume of A549 bearing mice treated with PBS, integrin β1 neutralizing antibody, PTX, and PTX combined with integrin β1 neutralizing antibody. (b) Survival time of A549 bearing mice treated with PBS, integrin β1 neutralizing antibody, PTX, and PTX combined with integrin β1 neutralizing antibody. (c) Tumor volume of A549 bearing mice treated with PBS, integrin β1 neutralizing antibody, Cis, and Cis combined with integrin β1 neutralizing antibody. (d) Survival time of A549 bearing mice treated with PBS, integrin β1 neutralizing antibody, Cis, and Cis combined with integrin β1 neutralizing antibody. (e) Tumor volume of 3D fibrin gels cultured A549 bearing mice treated with PBS, integrin β1 neutralizing antibody, PTX, and PTX combined with integrin β1 neutralizing antibody. (f) Survival time of 3D fibrin gels cultured A549 bearing mice treated with PBS, integrin β1 neutralizing antibody, PTX, and PTX combined with integrin β1 neutralizing antibody. * indicates P < 0.05. ** indicates P < 0.01.
Figure 4

Suppression of integrin signals strengthened anticancer effects of chemotherapy. (a) Tumor volume of A549 bearing mice treated with PBS, integrin β1 neutralizing antibody, PTX, and PTX combined with integrin β1 neutralizing antibody. (b) Survival time of A549 bearing mice treated with PBS, integrin β1 neutralizing antibody, PTX, and PTX combined with integrin β1 neutralizing antibody. (c) Tumor volume of A549 bearing mice treated with PBS, integrin β1 neutralizing antibody, Cis, and Cis combined with integrin β1 neutralizing antibody. (d) Survival time of A549 bearing mice treated with PBS, integrin β1 neutralizing antibody, Cis, and Cis combined with integrin β1 neutralizing antibody. (e) Tumor volume of 3D fibrin gels cultured A549 bearing mice treated with PBS, integrin β1 neutralizing antibody, PTX, and PTX combined with integrin β1 neutralizing antibody. (f) Survival time of 3D fibrin gels cultured A549 bearing mice treated with PBS, integrin β1 neutralizing antibody, PTX, and PTX combined with integrin β1 neutralizing antibody. * indicates P < 0.05. ** indicates P < 0.01.

4 Discussion

This study provides valuable insight into the role of fibrin in the growth and stemness remodeling of NSCLC cells. Our immunohistochemical analysis of patient samples revealed elevated expression of fibrin in high-degree NSCLC tissues, indicating its potential involvement in tumor progression [29]. Furthermore, we demonstrated that culturing NSCLC cells in 3D fibrin gels significantly enhanced their proliferative capacity and tumorigenic potential compared to 3D collagen gels. Importantly, we proposed that fibrin-induced tumor progression is mediated through the integrin β1/PTEN/AKT signaling pathway. Inhibition of this pathway by blocking integrin β1 or PTEN resulted in suppressed tumor growth and improved outcomes of chemotherapy.

Research has extensively demonstrated the tumor-promoting effects of ECM-derived fibrin. Fibrin plays a significant role in facilitating the migration and infiltration of tumor cells through various mechanisms, including thrombin activation, angiogenesis promotion, and regulation of tumor cell–ECM interactions [1214]. Furthermore, fibrin acts as a regulator of the release of cytokines [30] and growth factors [11] within the tumor microenvironment. Tumor angiogenesis, a pivotal stage in tumor development, is also influenced by fibrin. Fibrin has been shown to enhance endothelial cell migration and proliferation while modulating angiogenesis-related signaling pathways [31,32]. It is also involved in maintaining the stability of blood vessel structure and regulating vascular permeability. In addition to its effects on angiogenesis, fibrin has been implicated in immune evasion, which is a significant characteristic of tumor progression [12]. Fibrin can regulate tumor cell–immune cell interactions, leading to the suppression of immune responses and fostering tumor escape. Additionally, fibrin has been identified as a modulator of tumor-related inflammatory reactions [33]. Our study further contributes to the understanding of fibrin’s role in governing the stemness of lung cancer cells and sheds light on their resistance mechanisms. Notably, previous studies have suggested that fibrinogen, a homolog of fibrin [34], can bind to integrin αvβ3 and potentiate its ability to stimulate the proliferation of endothelial or tumor cells [35,36]. However, our study revealed that fibrin-induced NSCLC cell growth occurs through an integrin αvβ3-independent pathway [37]. Instead, the activation of pro-survival signals in NSCLC cells requires integrin β1-mediated interaction with fibrin. Suppression of integrin β1 signaling using neutralizing antibodies impaired downstream AKT signaling [38] and reduced tumor growth in mouse models. These findings highlight the potential of targeting integrin β1 as an innovative therapeutic strategy for NSCLC.

PTEN, a dual-specificity protein kinase, plays a crucial role in inhibiting the PI3K/Akt/mTOR signaling pathway by dephosphorylating PI3K [39]. As a significant tumor suppressor gene, PTEN governs cellular processes such as proliferation, apoptosis, and signal transduction. Recently, the relationship between PTEN and tumors has garnered considerable attention within the research community [40]. Genetic alterations such as PTEN loss, mutation, or silencing are frequently observed across various tumor types. These modifications culminated in the functional impairment or complete loss of PTEN, leading to sustained activation of the PI3K/Akt/mTOR signaling pathway, promoting uncontrolled cell proliferation and survival [41]. Consistent with previous investigations, our study confirms that fibrin decreases PTEN expression in lung cancer cells, subsequently activating the AKT signaling pathway. Furthermore, PTEN deficiency impedes apoptotic processes, rendering tumor cells impervious to cell death signals. Notably, our study revealed that decreased PTEN levels contribute to the development of drug resistance in lung cancer. In clinical research, the expression of PTEN, a tumor suppressor, has been closely associated with the prognosis of various cancer types, including breast and prostate cancer, among others. Our study provides evidence that PTEN serves as a tumor suppressor during NSCLC development. In the presence of fibrin, suppression of PTEN expression by integrin β1 leads to the activation of AKT signaling. Decreased PTEN expression and increased AKT expression correlate with the progression of high-degree NSCLC in clinical settings, indicating that PTEN/AKT signaling may serve as an indicator for NSCLC diagnosis or progression analysis.

In summary, our findings demonstrate the critical role of fibrin in NSCLC development through the integrin β1/PTEN/AKT signaling pathway. Targeting integrin β1 may represent an innovative approach to improving outcomes in chemotherapy for NSCLC.

Acknowledgments

The authors sincerely acknowledge the financial support provided by Zhangzhou Affiliated Hospital of Fujian Medical University and the valuable assistance from all participants.

  1. Funding information: Authors state no funding involved.

  2. Author contributions: G.L. and Y.D. proposed and designed the study. G.L. and J.C. conducted experimental research and bioinformatic analyses. G.L. and J.X. interpreted the results. G.L., J.C., and J.X. organized the data and produced the figures. G.L. drafted the manuscript, and Y.D. revised it. All authors have read and approved this manuscript for publication.

  3. Conflict of interest: Authors state no conflict of interest.

  4. Data availability statement: The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.

References

[1] Thai AA, Solomon BJ, Sequist LV, Gainor JF, Heist RS. Lung cancer. Lancet. 2021;398(10299):535–54.Search in Google Scholar

[2] Romeo HE, Barreiro Arcos ML. Clinical relevance of stem cells in lung cancer. World J Stem Cell. 2023;15(6):576–88.Search in Google Scholar

[3] Wu X, Li M, Li Y, Deng Y, Ke S, Li F, et al. Fibroblast growth factor 11 (FGF11) promotes non-small cell lung cancer (NSCLC) progression by regulating hypoxia signaling pathway. J Transl Med. 2021;19(1):353.Search in Google Scholar

[4] Matarrese P, Vona R, Ascione B, Cittadini C, Tocci A, Mileo AM. Tumor microenvironmental cytokines drive NSCLC cell aggressiveness and drug-resistance via YAP-mediated autophagy. Cells. 2023;12(7):1–21.Search in Google Scholar

[5] Zhang H, Jiang H, Zhu L, Li J, Ma S. Cancer-associated fibroblasts in non-small cell lung cancer: recent advances and future perspectives. Cancer Lett. 2021;514:38–47.Search in Google Scholar

[6] Leight JL, Drain AP, Weaver VM. Extracellular matrix remodeling and stiffening modulate tumor phenotype and treatment response. Annu Rev Cancer Biol. 2017;1(1):313–4.Search in Google Scholar

[7] Kwaan HC, Lindholm PF. Fibrin and fibrinolysis in cancer. Semin Thromb Hemost. 2019;45(4):413–22.Search in Google Scholar

[8] Li M, Wang J, Wang C, Xia L, Xu J, Xie X, et al. Microenvironment remodeled by tumor and stromal cells elevates fibroblast-derived COL1A1 and facilitates ovarian cancer metastasis. Exp Cell Res. 2020;394(1):112153.Search in Google Scholar

[9] Wang M, Zhang G, Zhang Y, Cui X, Wang S, Gao S, et al. Fibrinogen alpha chain knockout promotes tumor growth and metastasis through integrin–AKT signaling pathway in lung cancer. Mol Cancer Res. 2020;18(7):943–54.Search in Google Scholar

[10] Chan JP, Merlini M, Gao H-X, Mendiola AS, Akassoglou K, Rubenstein JL, et al. Blood coagulation factor fibrinogen in tumor pathogenesis of central nervous system B-cell lymphoma. Am J Pathol. 2021;191(3):575–83.Search in Google Scholar

[11] Obermann WMJ, Brockhaus K, Eble JA. Platelets, constant and cooperative companions of sessile and disseminating tumor cells, crucially contribute to the tumor microenvironment. Front Cell Dev Biol. 2021;9:1–17.Search in Google Scholar

[12] Jing H, Wu X, Xiang M, Wang C, Novakovic VA, Shi J. Microparticle phosphatidylserine mediates coagulation: involvement in tumor progression and metastasis. Cancers (Basel). 2023;15(7):1–29.Search in Google Scholar

[13] Larsen JB, Hvas A-M. Thrombin: a pivotal player in hemostasis and beyond. Semin Thromb Hemost. 2021;47(7):759–74.Search in Google Scholar

[14] Seo J, Do Yoo J, Kim M, Shim G, Oh Y-K, Park R-W, et al. Fibrinolytic nanocages dissolve clots in the tumor microenvironment, improving the distribution and therapeutic efficacy of anticancer drugs. Exp Mol Med. 2021;53(10):1592–601.Search in Google Scholar

[15] Milsom C, Magnus N, Meehan B, Al-Nedawi K, Garnier D, Rak J. Tissue factor and cancer stem cells. Arterioscler Thromb Vasc Biol. 2009;29(12):2005–14.Search in Google Scholar

[16] Han X, Zha H, Yang F, Guo B, Zhu B. Tumor-derived tissue factor aberrantly activates complement and facilitates lung tumor progression via recruitment of myeloid-derived suppressor cells. Int J Mol Sci. 2017;18(1):22.Search in Google Scholar

[17] Simpson-Haidaris PJ, Rybarczyk B. Tumors and fibrinogen. Ann N Y Acad Sci. 2001;936(1):406–25.Search in Google Scholar

[18] Boorjian SA, Berglund RK, Maschino AC, Savage CJ, Herr HW. Fibrin clot inhibitor medication and efficacy of bacillus Calmette-Guerin for bladder urothelial cancer. J Urol. 2009;182(4):1306–12.Search in Google Scholar

[19] Liu Y, Liang X, Yin X, Lv J, Tang K, Ma J, et al. Blockade of IDO-kynurenine-AhR metabolic circuitry abrogates IFN-γ-induced immunologic dormancy of tumor-repopulating cells. Nat Commun. 2017;8(1):15207.Search in Google Scholar

[20] Shahid S, Iman A, Matti U, Rachid K, Assaf A, Eveno C, et al. Fibrin deposit on the peritoneal surface serves as a niche for cancer expansion in carcinomatosis patients. Neoplasia. 2019;21(11):1091–101.Search in Google Scholar

[21] Chang Y-T, Shih S-L, Loh E-W, Tam K-W. Effects of fibrin sealant on seroma reduction for patients with breast cancer undergoing axillary dissection: meta-analysis of randomized controlled trials. Ann Surg Oncol. 2020;27(13):5286–95.Search in Google Scholar

[22] Paw E, Vangaveti V, Zonta M, Heal C. Protocol for an open randomised controlled trial investigating Fibrin Glue in Skin grafts for Skin cancer (FiGSS). BMJ Open. 2022;12(11):e064431.Search in Google Scholar

[23] Zhang M, Xu C, Wang H-Z, Peng Y-N, Li H-O, Zhou Y-J, et al. Soft fibrin matrix downregulates DAB2IP to promote Nanog-dependent growth of colon tumor-repopulating cells. Cell Death Dis. 2019;10(3):151.Search in Google Scholar

[24] Teixeira AM, Martins P. A review of bioengineering techniques applied to breast tissue: mechanical properties, tissue engineering and finite element analysis. Front Bioeng Biotechnol. 2023;11:1–29.Search in Google Scholar

[25] Zhang Y, Zhang R, Zeng L, Wang H, Peng R, Zhang M, et al. Identification and validation of a potential stemness-associated biomarker in hepatocellular carcinoma. Stem Cell Int. 2022;2022:1534593.Search in Google Scholar

[26] Bourgot I, Primac I, Louis T, Noël A, Maquoi E. Reciprocal interplay between fibrillar collagens and collagen-binding integrins: implications in cancer progression and metastasis. Front Oncol. 2020;10:1–28.Search in Google Scholar

[27] Luo X, Geng D, Zhang Q, Ye T, Zhang Y, Li Z, et al. Recombinant expression a novel fibronectin–collage fusion peptide modulating stem cell stemness via integrin β3. Appl Microbiol Biotechnol. 2022;106(9):3765–76.Search in Google Scholar

[28] Zhang Y, Park J, Han S-J, Yang SY, Yoon HJ, Park I, et al. Redox regulation of tumor suppressor PTEN in cell signaling. Redox Biol. 2020;34:101553.Search in Google Scholar

[29] Zhang H, Yu Y, Zhou L, Ma J, Tang K, Xu P, et al. Circulating tumor microparticles promote lung metastasis by reprogramming inflammatory and mechanical niches via a macrophage-dependent pathway. Cancer Immunol Res. 2018;6(9):1046–56.Search in Google Scholar

[30] Alexander ET, Gilmour SK. Immunomodulatory role of thrombin in cancer progression. Mol Carcinog. 2022;61(6):527–36.Search in Google Scholar

[31] Agathe F, Yasuhiro N, Yukari S-M, Tomomi F, Kaoru S, Matsusaki M. An in vitro self-organized three-dimensional model of the blood–brain barrier microvasculature. Biomed Mater. 2021;16(1):015006.Search in Google Scholar

[32] Zhang Y, Kong Y, Guo H, Liu Y, Zang Y, Li J. Inner nuclear membrane protein TMEM201 maintains endothelial cell migration and angiogenesis by interacting with the LINC complex. J Mol Cell Biol. 2022;14(3):1–13.Search in Google Scholar

[33] Fu L, Liu Z, Liu Y. Fibrinogen-like protein 2 in inflammatory diseases: a future therapeutic target. Int Immunopharmacol. 2023;116:109799.Search in Google Scholar

[34] Nelson AC, Fogelson AL. Towards understanding the effect of fibrinogen interactions on fibrin gel structure. Phys Rev E. 2023;107(2):024413.Search in Google Scholar

[35] Liu S. Radiolabeled cyclic RGD peptides as integrin αvβ3-targeted radiotracers: maximizing binding affinity via bivalency. Bioconjugate Chem. 2009;20(12):2199–213.Search in Google Scholar

[36] Fabricius E-M, Wildner G-P, Kruse-Boitschenko U, Hoffmeister B, Goodman SL, Raguse J-D. Immunohistochemical analysis of integrins αvβ3, αvβ5 and α5β1, and their ligands, fibrinogen, fibronectin, osteopontin and vitronectin, in frozen sections of human oral head and neck squamous cell carcinomas. Exp Ther Med. 2011;2(1):9–19.Search in Google Scholar

[37] Zhou W, Ma J, Meng L, Liu D, Chen J. Deletion of TRIB3 disrupts the tumor progression induced by integrin αvβ3 in lung cancer. BMC Cancer. 2022;22(1):459.Search in Google Scholar

[38] Hu L, Wang J, Wang Y, Xu H. An integrin αvβ3 antagonistic modified peptide inhibits tumor growth through inhibition of the ERK and AKT signaling pathways. Oncol Rep. 2016;36(4):1953–62.Search in Google Scholar

[39] Mukherjee R, Vanaja KG, Boyer JA, Gadal S, Solomon H, Chandarlapaty S, et al. Regulation of PTEN translation by PI3K signaling maintains pathway homeostasis. Mol Cell. 2021;81(4):708–23.e5.Search in Google Scholar

[40] Cetintas VB, Batada NN. Is there a causal link between PTEN deficient tumors and immunosuppressive tumor microenvironment? J Transl Med. 2020;18(1):45.Search in Google Scholar

[41] Wang J, Lv X, Guo X, Dong Y, Peng P, Huang F, et al. Feedback activation of STAT3 limits the response to PI3K/AKT/mTOR inhibitors in PTEN-deficient cancer cells. Oncogenesis. 2021;10(1):8.Search in Google Scholar

Received: 2023-05-18
Revised: 2023-08-08
Accepted: 2023-08-09
Published Online: 2023-09-19

© 2023 the author(s), published by De Gruyter

This work is licensed under the Creative Commons Attribution 4.0 International License.

Articles in the same Issue

  1. Biomedical Sciences
  2. Systemic investigation of inetetamab in combination with small molecules to treat HER2-overexpressing breast and gastric cancers
  3. Immunosuppressive treatment for idiopathic membranous nephropathy: An updated network meta-analysis
  4. Identifying two pathogenic variants in a patient with pigmented paravenous retinochoroidal atrophy
  5. Effects of phytoestrogens combined with cold stress on sperm parameters and testicular proteomics in rats
  6. A case of pulmonary embolism with bad warfarin anticoagulant effects caused by E. coli infection
  7. Neutrophilia with subclinical Cushing’s disease: A case report and literature review
  8. Isoimperatorin alleviates lipopolysaccharide-induced periodontitis by downregulating ERK1/2 and NF-κB pathways
  9. Immunoregulation of synovial macrophages for the treatment of osteoarthritis
  10. Novel CPLANE1 c.8948dupT (p.P2984Tfs*7) variant in a child patient with Joubert syndrome
  11. Antiphospholipid antibodies and the risk of thrombosis in myeloproliferative neoplasms
  12. Immunological responses of septic rats to combination therapy with thymosin α1 and vitamin C
  13. High glucose and high lipid induced mitochondrial dysfunction in JEG-3 cells through oxidative stress
  14. Pharmacological inhibition of the ubiquitin-specific protease 8 effectively suppresses glioblastoma cell growth
  15. Levocarnitine regulates the growth of angiotensin II-induced myocardial fibrosis cells via TIMP-1
  16. Age-related changes in peripheral T-cell subpopulations in elderly individuals: An observational study
  17. Single-cell transcription analysis reveals the tumor origin and heterogeneity of human bilateral renal clear cell carcinoma
  18. Identification of iron metabolism-related genes as diagnostic signatures in sepsis by blood transcriptomic analysis
  19. Long noncoding RNA ACART knockdown decreases 3T3-L1 preadipocyte proliferation and differentiation
  20. Surgery, adjuvant immunotherapy plus chemotherapy and radiotherapy for primary malignant melanoma of the parotid gland (PGMM): A case report
  21. Dosimetry comparison with helical tomotherapy, volumetric modulated arc therapy, and intensity-modulated radiotherapy for grade II gliomas: A single‑institution case series
  22. Soy isoflavone reduces LPS-induced acute lung injury via increasing aquaporin 1 and aquaporin 5 in rats
  23. Refractory hypokalemia with sexual dysplasia and infertility caused by 17α-hydroxylase deficiency and triple X syndrome: A case report
  24. Meta-analysis of cancer risk among end stage renal disease undergoing maintenance dialysis
  25. 6-Phosphogluconate dehydrogenase inhibition arrests growth and induces apoptosis in gastric cancer via AMPK activation and oxidative stress
  26. Experimental study on the optimization of ANM33 release in foam cells
  27. Primary retroperitoneal angiosarcoma: A case report
  28. Metabolomic analysis-identified 2-hydroxybutyric acid might be a key metabolite of severe preeclampsia
  29. Malignant pleural effusion diagnosis and therapy
  30. Effect of spaceflight on the phenotype and proteome of Escherichia coli
  31. Comparison of immunotherapy combined with stereotactic radiotherapy and targeted therapy for patients with brain metastases: A systemic review and meta-analysis
  32. Activation of hypermethylated P2RY1 mitigates gastric cancer by promoting apoptosis and inhibiting proliferation
  33. Association between the VEGFR-2 -604T/C polymorphism (rs2071559) and type 2 diabetic retinopathy
  34. The role of IL-31 and IL-34 in the diagnosis and treatment of chronic periodontitis
  35. Triple-negative mouse breast cancer initiating cells show high expression of beta1 integrin and increased malignant features
  36. mNGS facilitates the accurate diagnosis and antibiotic treatment of suspicious critical CNS infection in real practice: A retrospective study
  37. The apatinib and pemetrexed combination has antitumor and antiangiogenic effects against NSCLC
  38. Radiotherapy for primary thyroid adenoid cystic carcinoma
  39. Design and functional preliminary investigation of recombinant antigen EgG1Y162–EgG1Y162 against Echinococcus granulosus
  40. Effects of losartan in patients with NAFLD: A meta-analysis of randomized controlled trial
  41. Bibliometric analysis of METTL3: Current perspectives, highlights, and trending topics
  42. Performance comparison of three scaling algorithms in NMR-based metabolomics analysis
  43. PI3K/AKT/mTOR pathway and its related molecules participate in PROK1 silence-induced anti-tumor effects on pancreatic cancer
  44. The altered expression of cytoskeletal and synaptic remodeling proteins during epilepsy
  45. Effects of pegylated recombinant human granulocyte colony-stimulating factor on lymphocytes and white blood cells of patients with malignant tumor
  46. Prostatitis as initial manifestation of Chlamydia psittaci pneumonia diagnosed by metagenome next-generation sequencing: A case report
  47. NUDT21 relieves sevoflurane-induced neurological damage in rats by down-regulating LIMK2
  48. Association of interleukin-10 rs1800896, rs1800872, and interleukin-6 rs1800795 polymorphisms with squamous cell carcinoma risk: A meta-analysis
  49. Exosomal HBV-DNA for diagnosis and treatment monitoring of chronic hepatitis B
  50. Shear stress leads to the dysfunction of endothelial cells through the Cav-1-mediated KLF2/eNOS/ERK signaling pathway under physiological conditions
  51. Interaction between the PI3K/AKT pathway and mitochondrial autophagy in macrophages and the leukocyte count in rats with LPS-induced pulmonary infection
  52. Meta-analysis of the rs231775 locus polymorphism in the CTLA-4 gene and the susceptibility to Graves’ disease in children
  53. Cloning, subcellular localization and expression of phosphate transporter gene HvPT6 of hulless barley
  54. Coptisine mitigates diabetic nephropathy via repressing the NRLP3 inflammasome
  55. Significant elevated CXCL14 and decreased IL-39 levels in patients with tuberculosis
  56. Whole-exome sequencing applications in prenatal diagnosis of fetal bowel dilatation
  57. Gemella morbillorum infective endocarditis: A case report and literature review
  58. An unusual ectopic thymoma clonal evolution analysis: A case report
  59. Severe cumulative skin toxicity during toripalimab combined with vemurafenib following toripalimab alone
  60. Detection of V. vulnificus septic shock with ARDS using mNGS
  61. Novel rare genetic variants of familial and sporadic pulmonary atresia identified by whole-exome sequencing
  62. The influence and mechanistic action of sperm DNA fragmentation index on the outcomes of assisted reproduction technology
  63. Novel compound heterozygous mutations in TELO2 in an infant with You-Hoover-Fong syndrome: A case report and literature review
  64. ctDNA as a prognostic biomarker in resectable CLM: Systematic review and meta-analysis
  65. Diagnosis of primary amoebic meningoencephalitis by metagenomic next-generation sequencing: A case report
  66. Phylogenetic analysis of promoter regions of human Dolichol kinase (DOLK) and orthologous genes using bioinformatics tools
  67. Collagen changes in rabbit conjunctiva after conjunctival crosslinking
  68. Effects of NM23 transfection of human gastric carcinoma cells in mice
  69. Oral nifedipine and phytosterol, intravenous nicardipine, and oral nifedipine only: Three-arm, retrospective, cohort study for management of severe preeclampsia
  70. Case report of hepatic retiform hemangioendothelioma: A rare tumor treated with ultrasound-guided microwave ablation
  71. Curcumin induces apoptosis in human hepatocellular carcinoma cells by decreasing the expression of STAT3/VEGF/HIF-1α signaling
  72. Rare presentation of double-clonal Waldenström macroglobulinemia with pulmonary embolism: A case report
  73. Giant duplication of the transverse colon in an adult: A case report and literature review
  74. Ectopic thyroid tissue in the breast: A case report
  75. SDR16C5 promotes proliferation and migration and inhibits apoptosis in pancreatic cancer
  76. Vaginal metastasis from breast cancer: A case report
  77. Screening of the best time window for MSC transplantation to treat acute myocardial infarction with SDF-1α antibody-loaded targeted ultrasonic microbubbles: An in vivo study in miniswine
  78. Inhibition of TAZ impairs the migration ability of melanoma cells
  79. Molecular complexity analysis of the diagnosis of Gitelman syndrome in China
  80. Effects of maternal calcium and protein intake on the development and bone metabolism of offspring mice
  81. Identification of winter wheat pests and diseases based on improved convolutional neural network
  82. Ultra-multiplex PCR technique to guide treatment of Aspergillus-infected aortic valve prostheses
  83. Virtual high-throughput screening: Potential inhibitors targeting aminopeptidase N (CD13) and PIKfyve for SARS-CoV-2
  84. Immune checkpoint inhibitors in cancer patients with COVID-19
  85. Utility of methylene blue mixed with autologous blood in preoperative localization of pulmonary nodules and masses
  86. Integrated analysis of the microbiome and transcriptome in stomach adenocarcinoma
  87. Berberine suppressed sarcopenia insulin resistance through SIRT1-mediated mitophagy
  88. DUSP2 inhibits the progression of lupus nephritis in mice by regulating the STAT3 pathway
  89. Lung abscess by Fusobacterium nucleatum and Streptococcus spp. co-infection by mNGS: A case series
  90. Genetic alterations of KRAS and TP53 in intrahepatic cholangiocarcinoma associated with poor prognosis
  91. Granulomatous polyangiitis involving the fourth ventricle: Report of a rare case and a literature review
  92. Studying infant mortality: A demographic analysis based on data mining models
  93. Metaplastic breast carcinoma with osseous differentiation: A report of a rare case and literature review
  94. Protein Z modulates the metastasis of lung adenocarcinoma cells
  95. Inhibition of pyroptosis and apoptosis by capsaicin protects against LPS-induced acute kidney injury through TRPV1/UCP2 axis in vitro
  96. TAK-242, a toll-like receptor 4 antagonist, against brain injury by alleviates autophagy and inflammation in rats
  97. Primary mediastinum Ewing’s sarcoma with pleural effusion: A case report and literature review
  98. Association of ADRB2 gene polymorphisms and intestinal microbiota in Chinese Han adolescents
  99. Tanshinone IIA alleviates chondrocyte apoptosis and extracellular matrix degeneration by inhibiting ferroptosis
  100. Study on the cytokines related to SARS-Cov-2 in testicular cells and the interaction network between cells based on scRNA-seq data
  101. Effect of periostin on bone metabolic and autophagy factors during tooth eruption in mice
  102. HP1 induces ferroptosis of renal tubular epithelial cells through NRF2 pathway in diabetic nephropathy
  103. Intravaginal estrogen management in postmenopausal patients with vaginal squamous intraepithelial lesions along with CO2 laser ablation: A retrospective study
  104. Hepatocellular carcinoma cell differentiation trajectory predicts immunotherapy, potential therapeutic drugs, and prognosis of patients
  105. Effects of physical exercise on biomarkers of oxidative stress in healthy subjects: A meta-analysis of randomized controlled trials
  106. Identification of lysosome-related genes in connection with prognosis and immune cell infiltration for drug candidates in head and neck cancer
  107. Development of an instrument-free and low-cost ELISA dot-blot test to detect antibodies against SARS-CoV-2
  108. Research progress on gas signal molecular therapy for Parkinson’s disease
  109. Adiponectin inhibits TGF-β1-induced skin fibroblast proliferation and phenotype transformation via the p38 MAPK signaling pathway
  110. The G protein-coupled receptor-related gene signatures for predicting prognosis and immunotherapy response in bladder urothelial carcinoma
  111. α-Fetoprotein contributes to the malignant biological properties of AFP-producing gastric cancer
  112. CXCL12/CXCR4/CXCR7 axis in placenta tissues of patients with placenta previa
  113. Association between thyroid stimulating hormone levels and papillary thyroid cancer risk: A meta-analysis
  114. Significance of sTREM-1 and sST2 combined diagnosis for sepsis detection and prognosis prediction
  115. Diagnostic value of serum neuroactive substances in the acute exacerbation of chronic obstructive pulmonary disease complicated with depression
  116. Research progress of AMP-activated protein kinase and cardiac aging
  117. TRIM29 knockdown prevented the colon cancer progression through decreasing the ubiquitination levels of KRT5
  118. Cross-talk between gut microbiota and liver steatosis: Complications and therapeutic target
  119. Metastasis from small cell lung cancer to ovary: A case report
  120. The early diagnosis and pathogenic mechanisms of sepsis-related acute kidney injury
  121. The effect of NK cell therapy on sepsis secondary to lung cancer: A case report
  122. Erianin alleviates collagen-induced arthritis in mice by inhibiting Th17 cell differentiation
  123. Loss of ACOX1 in clear cell renal cell carcinoma and its correlation with clinical features
  124. Signalling pathways in the osteogenic differentiation of periodontal ligament stem cells
  125. Crosstalk between lactic acid and immune regulation and its value in the diagnosis and treatment of liver failure
  126. Clinicopathological features and differential diagnosis of gastric pleomorphic giant cell carcinoma
  127. Traumatic brain injury and rTMS-ERPs: Case report and literature review
  128. Extracellular fibrin promotes non-small cell lung cancer progression through integrin β1/PTEN/AKT signaling
  129. Knockdown of DLK4 inhibits non-small cell lung cancer tumor growth by downregulating CKS2
  130. The co-expression pattern of VEGFR-2 with indicators related to proliferation, apoptosis, and differentiation of anagen hair follicles
  131. Inflammation-related signaling pathways in tendinopathy
  132. CD4+ T cell count in HIV/TB co-infection and co-occurrence with HL: Case report and literature review
  133. Clinical analysis of severe Chlamydia psittaci pneumonia: Case series study
  134. Bioinformatics analysis to identify potential biomarkers for the pulmonary artery hypertension associated with the basement membrane
  135. Influence of MTHFR polymorphism, alone or in combination with smoking and alcohol consumption, on cancer susceptibility
  136. Catharanthus roseus (L.) G. Don counteracts the ampicillin resistance in multiple antibiotic-resistant Staphylococcus aureus by downregulation of PBP2a synthesis
  137. Combination of a bronchogenic cyst in the thoracic spinal canal with chronic myelocytic leukemia
  138. Bacterial lipoprotein plays an important role in the macrophage autophagy and apoptosis induced by Salmonella typhimurium and Staphylococcus aureus
  139. TCL1A+ B cells predict prognosis in triple-negative breast cancer through integrative analysis of single-cell and bulk transcriptomic data
  140. Ezrin promotes esophageal squamous cell carcinoma progression via the Hippo signaling pathway
  141. Ferroptosis: A potential target of macrophages in plaque vulnerability
  142. Predicting pediatric Crohn's disease based on six mRNA-constructed risk signature using comprehensive bioinformatic approaches
  143. Applications of genetic code expansion and photosensitive UAAs in studying membrane proteins
  144. HK2 contributes to the proliferation, migration, and invasion of diffuse large B-cell lymphoma cells by enhancing the ERK1/2 signaling pathway
  145. IL-17 in osteoarthritis: A narrative review
  146. Circadian cycle and neuroinflammation
  147. Probiotic management and inflammatory factors as a novel treatment in cirrhosis: A systematic review and meta-analysis
  148. Hemorrhagic meningioma with pulmonary metastasis: Case report and literature review
  149. SPOP regulates the expression profiles and alternative splicing events in human hepatocytes
  150. Knockdown of SETD5 inhibited glycolysis and tumor growth in gastric cancer cells by down-regulating Akt signaling pathway
  151. PTX3 promotes IVIG resistance-induced endothelial injury in Kawasaki disease by regulating the NF-κB pathway
  152. Pancreatic ectopic thyroid tissue: A case report and analysis of literature
  153. The prognostic impact of body mass index on female breast cancer patients in underdeveloped regions of northern China differs by menopause status and tumor molecular subtype
  154. Report on a case of liver-originating malignant melanoma of unknown primary
  155. Case report: Herbal treatment of neutropenic enterocolitis after chemotherapy for breast cancer
  156. The fibroblast growth factor–Klotho axis at molecular level
  157. Characterization of amiodarone action on currents in hERG-T618 gain-of-function mutations
  158. A case report of diagnosis and dynamic monitoring of Listeria monocytogenes meningitis with NGS
  159. Effect of autologous platelet-rich plasma on new bone formation and viability of a Marburg bone graft
  160. Small breast epithelial mucin as a useful prognostic marker for breast cancer patients
  161. Continuous non-adherent culture promotes transdifferentiation of human adipose-derived stem cells into retinal lineage
  162. Nrf3 alleviates oxidative stress and promotes the survival of colon cancer cells by activating AKT/BCL-2 signal pathway
  163. Favorable response to surufatinib in a patient with necrolytic migratory erythema: A case report
  164. Case report of atypical undernutrition of hypoproteinemia type
  165. Down-regulation of COL1A1 inhibits tumor-associated fibroblast activation and mediates matrix remodeling in the tumor microenvironment of breast cancer
  166. Sarcoma protein kinase inhibition alleviates liver fibrosis by promoting hepatic stellate cells ferroptosis
  167. Research progress of serum eosinophil in chronic obstructive pulmonary disease and asthma
  168. Clinicopathological characteristics of co-existing or mixed colorectal cancer and neuroendocrine tumor: Report of five cases
  169. Role of menopausal hormone therapy in the prevention of postmenopausal osteoporosis
  170. Precisional detection of lymph node metastasis using tFCM in colorectal cancer
  171. Advances in diagnosis and treatment of perimenopausal syndrome
  172. A study of forensic genetics: ITO index distribution and kinship judgment between two individuals
  173. Acute lupus pneumonitis resembling miliary tuberculosis: A case-based review
  174. Plasma levels of CD36 and glutathione as biomarkers for ruptured intracranial aneurysm
  175. Fractalkine modulates pulmonary angiogenesis and tube formation by modulating CX3CR1 and growth factors in PVECs
  176. Novel risk prediction models for deep vein thrombosis after thoracotomy and thoracoscopic lung cancer resections, involving coagulation and immune function
  177. Exploring the diagnostic markers of essential tremor: A study based on machine learning algorithms
  178. Evaluation of effects of small-incision approach treatment on proximal tibia fracture by deep learning algorithm-based magnetic resonance imaging
  179. An online diagnosis method for cancer lesions based on intelligent imaging analysis
  180. Medical imaging in rheumatoid arthritis: A review on deep learning approach
  181. Predictive analytics in smart healthcare for child mortality prediction using a machine learning approach
  182. Utility of neutrophil–lymphocyte ratio and platelet–lymphocyte ratio in predicting acute-on-chronic liver failure survival
  183. A biomedical decision support system for meta-analysis of bilateral upper-limb training in stroke patients with hemiplegia
  184. TNF-α and IL-8 levels are positively correlated with hypobaric hypoxic pulmonary hypertension and pulmonary vascular remodeling in rats
  185. Stochastic gradient descent optimisation for convolutional neural network for medical image segmentation
  186. Comparison of the prognostic value of four different critical illness scores in patients with sepsis-induced coagulopathy
  187. Application and teaching of computer molecular simulation embedded technology and artificial intelligence in drug research and development
  188. Hepatobiliary surgery based on intelligent image segmentation technology
  189. Value of brain injury-related indicators based on neural network in the diagnosis of neonatal hypoxic-ischemic encephalopathy
  190. Analysis of early diagnosis methods for asymmetric dementia in brain MR images based on genetic medical technology
  191. Early diagnosis for the onset of peri-implantitis based on artificial neural network
  192. Clinical significance of the detection of serum IgG4 and IgG4/IgG ratio in patients with thyroid-associated ophthalmopathy
  193. Forecast of pain degree of lumbar disc herniation based on back propagation neural network
  194. SPA-UNet: A liver tumor segmentation network based on fused multi-scale features
  195. Systematic evaluation of clinical efficacy of CYP1B1 gene polymorphism in EGFR mutant non-small cell lung cancer observed by medical image
  196. Rehabilitation effect of intelligent rehabilitation training system on hemiplegic limb spasms after stroke
  197. A novel approach for minimising anti-aliasing effects in EEG data acquisition
  198. ErbB4 promotes M2 activation of macrophages in idiopathic pulmonary fibrosis
  199. Clinical role of CYP1B1 gene polymorphism in prediction of postoperative chemotherapy efficacy in NSCLC based on individualized health model
  200. Lung nodule segmentation via semi-residual multi-resolution neural networks
  201. Evaluation of brain nerve function in ICU patients with Delirium by deep learning algorithm-based resting state MRI
  202. A data mining technique for detecting malignant mesothelioma cancer using multiple regression analysis
  203. Markov model combined with MR diffusion tensor imaging for predicting the onset of Alzheimer’s disease
  204. Effectiveness of the treatment of depression associated with cancer and neuroimaging changes in depression-related brain regions in patients treated with the mediator-deuterium acupuncture method
  205. Molecular mechanism of colorectal cancer and screening of molecular markers based on bioinformatics analysis
  206. Monitoring and evaluation of anesthesia depth status data based on neuroscience
  207. Exploring the conformational dynamics and thermodynamics of EGFR S768I and G719X + S768I mutations in non-small cell lung cancer: An in silico approaches
  208. Optimised feature selection-driven convolutional neural network using gray level co-occurrence matrix for detection of cervical cancer
  209. Incidence of different pressure patterns of spinal cerebellar ataxia and analysis of imaging and genetic diagnosis
  210. Pathogenic bacteria and treatment resistance in older cardiovascular disease patients with lung infection and risk prediction model
  211. Adoption value of support vector machine algorithm-based computed tomography imaging in the diagnosis of secondary pulmonary fungal infections in patients with malignant hematological disorders
  212. From slides to insights: Harnessing deep learning for prognostic survival prediction in human colorectal cancer histology
  213. Ecology and Environmental Science
  214. Monitoring of hourly carbon dioxide concentration under different land use types in arid ecosystem
  215. Comparing the differences of prokaryotic microbial community between pit walls and bottom from Chinese liquor revealed by 16S rRNA gene sequencing
  216. Effects of cadmium stress on fruits germination and growth of two herbage species
  217. Bamboo charcoal affects soil properties and bacterial community in tea plantations
  218. Optimization of biogas potential using kinetic models, response surface methodology, and instrumental evidence for biodegradation of tannery fleshings during anaerobic digestion
  219. Understory vegetation diversity patterns of Platycladus orientalis and Pinus elliottii communities in Central and Southern China
  220. Studies on macrofungi diversity and discovery of new species of Abortiporus from Baotianman World Biosphere Reserve
  221. Food Science
  222. Effect of berrycactus fruit (Myrtillocactus geometrizans) on glutamate, glutamine, and GABA levels in the frontal cortex of rats fed with a high-fat diet
  223. Guesstimate of thymoquinone diversity in Nigella sativa L. genotypes and elite varieties collected from Indian states using HPTLC technique
  224. Analysis of bacterial community structure of Fuzhuan tea with different processing techniques
  225. Untargeted metabolomics reveals sour jujube kernel benefiting the nutritional value and flavor of Morchella esculenta
  226. Mycobiota in Slovak wine grapes: A case study from the small Carpathians wine region
  227. Elemental analysis of Fadogia ancylantha leaves used as a nutraceutical in Mashonaland West Province, Zimbabwe
  228. Microbiological transglutaminase: Biotechnological application in the food industry
  229. Influence of solvent-free extraction of fish oil from catfish (Clarias magur) heads using a Taguchi orthogonal array design: A qualitative and quantitative approach
  230. Chromatographic analysis of the chemical composition and anticancer activities of Curcuma longa extract cultivated in Palestine
  231. The potential for the use of leghemoglobin and plant ferritin as sources of iron
  232. Investigating the association between dietary patterns and glycemic control among children and adolescents with T1DM
  233. Bioengineering and Biotechnology
  234. Biocompatibility and osteointegration capability of β-TCP manufactured by stereolithography 3D printing: In vitro study
  235. Clinical characteristics and the prognosis of diabetic foot in Tibet: A single center, retrospective study
  236. Agriculture
  237. Biofertilizer and NPSB fertilizer application effects on nodulation and productivity of common bean (Phaseolus vulgaris L.) at Sodo Zuria, Southern Ethiopia
  238. On correlation between canopy vegetation and growth indexes of maize varieties with different nitrogen efficiencies
  239. Exopolysaccharides from Pseudomonas tolaasii inhibit the growth of Pleurotus ostreatus mycelia
  240. A transcriptomic evaluation of the mechanism of programmed cell death of the replaceable bud in Chinese chestnut
  241. Melatonin enhances salt tolerance in sorghum by modulating photosynthetic performance, osmoregulation, antioxidant defense, and ion homeostasis
  242. Effects of plant density on alfalfa (Medicago sativa L.) seed yield in western Heilongjiang areas
  243. Identification of rice leaf diseases and deficiency disorders using a novel DeepBatch technique
  244. Artificial intelligence and internet of things oriented sustainable precision farming: Towards modern agriculture
  245. Animal Sciences
  246. Effect of ketogenic diet on exercise tolerance and transcriptome of gastrocnemius in mice
  247. Combined analysis of mRNA–miRNA from testis tissue in Tibetan sheep with different FecB genotypes
  248. Isolation, identification, and drug resistance of a partially isolated bacterium from the gill of Siniperca chuatsi
  249. Tracking behavioral changes of confined sows from the first mating to the third parity
  250. The sequencing of the key genes and end products in the TLR4 signaling pathway from the kidney of Rana dybowskii exposed to Aeromonas hydrophila
  251. Development of a new candidate vaccine against piglet diarrhea caused by Escherichia coli
  252. Plant Sciences
  253. Crown and diameter structure of pure Pinus massoniana Lamb. forest in Hunan province, China
  254. Genetic evaluation and germplasm identification analysis on ITS2, trnL-F, and psbA-trnH of alfalfa varieties germplasm resources
  255. Tissue culture and rapid propagation technology for Gentiana rhodantha
  256. Effects of cadmium on the synthesis of active ingredients in Salvia miltiorrhiza
  257. Cloning and expression analysis of VrNAC13 gene in mung bean
  258. Chlorate-induced molecular floral transition revealed by transcriptomes
  259. Effects of warming and drought on growth and development of soybean in Hailun region
  260. Effects of different light conditions on transient expression and biomass in Nicotiana benthamiana leaves
  261. Comparative analysis of the rhizosphere microbiome and medicinally active ingredients of Atractylodes lancea from different geographical origins
  262. Distinguish Dianthus species or varieties based on chloroplast genomes
  263. Comparative transcriptomes reveal molecular mechanisms of apple blossoms of different tolerance genotypes to chilling injury
  264. Study on fresh processing key technology and quality influence of Cut Ophiopogonis Radix based on multi-index evaluation
  265. An advanced approach for fig leaf disease detection and classification: Leveraging image processing and enhanced support vector machine methodology
  266. Erratum
  267. Erratum to “Protein Z modulates the metastasis of lung adenocarcinoma cells”
  268. Erratum to “BRCA1 subcellular localization regulated by PI3K signaling pathway in triple-negative breast cancer MDA-MB-231 cells and hormone-sensitive T47D cells”
  269. Retraction
  270. Retraction to “Protocatechuic acid attenuates cerebral aneurysm formation and progression by inhibiting TNF-alpha/Nrf-2/NF-kB-mediated inflammatory mechanisms in experimental rats”
Downloaded on 27.1.2026 from https://www.degruyterbrill.com/document/doi/10.1515/biol-2022-0716/html
Scroll to top button